Sisram Medical Ltd
SRAMF
$0.60
$0.35139.23%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.33% | -41.33% | 12.49% | 12.49% | -42.05% |
| Total Depreciation and Amortization | 0.58% | 0.58% | 5.32% | 5.32% | 44.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.15% | -28.15% | -27.40% | -27.40% | 7.56% |
| Change in Net Operating Assets | -- | -- | -40.93% | -40.93% | -- |
| Cash from Operations | -223.48% | -223.48% | -18.94% | -18.94% | -50.54% |
| Capital Expenditure | -48.61% | -48.61% | 73.61% | 73.61% | 58.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -2,700.00% | -2,700.00% | 530.00% |
| Cash Acquisitions | -- | -- | 64.47% | 64.47% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.07% | -98.07% | -976.46% | -976.46% | 65.91% |
| Cash from Investing | -119.77% | -119.77% | -80.44% | -80.44% | 138.08% |
| Total Debt Issued | 559.48% | 559.48% | 85.48% | 85.48% | 49.87% |
| Total Debt Repaid | -323.25% | -323.25% | -35.98% | -35.98% | -5.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 10.09% | 10.09% | -- |
| Other Financing Activities | -466.21% | -466.21% | 126.70% | 126.70% | 84.03% |
| Cash from Financing | -96.71% | -96.71% | 16.63% | 16.63% | 44.17% |
| Foreign Exchange rate Adjustments | 355.62% | 355.62% | 101.55% | 101.55% | 50.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.39% | -204.39% | -100.10% | -100.10% | 141.83% |